Skip to content

Author

M. Kivipelto

We have 5 of 851 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

APOE4 allele modifies the effect of lifestyle interventions on cognition

The apolipoprotein E ε4 allele (APOE4) is the main genetic risk factor for incidence and earlier onset of dementia, and APOE4 carriers are thus considered a key target group for dementia risk reduction. APOE4 carriership also impacts the association between lifestyle and cognitive decline. Our meta-analysis inves...

J. Lehtisalo, Ari Solomon, E. Levälahti et al. · 0 citations
Open access Oct 2026

Cortical thickness signature of early-onset Alzheimer’s disease across clinical stages and A/T1 biomarker profiles

The cortical thinning signature of early-onset Alzheimer’s disease (EOAD) is well established in dementia, but its emergence during earlier disease stages remains unclear. We investigated when it becomes detectable and whether it differs according to fluid amyloid and phosphorylated-tau (A/T1) biomarker profiles. We st...

A. Zilioli, R. Mohanty, A. Rosenberg et al. · 0 citations
Open access Sep 2026

Cerebral microbleed assessment on MRI in a memory clinic: Reliability, prevalence, and implications for anti‐amyloid therapy

Abstract INTRODUCTION Cerebral microbleeds (CMBs) represent an important magnetic resonance imaging (MRI) marker of cerebral small vessel pathology in memory‐clinic populations, where vascular and neurodegenerative pathologies frequently overlap. METHODS This cross‐sectional study included 747 patients from a Swedish m...

Ernest Privšek, A. Marseglia, Igor Košutić et al. · 0 citations
Open access Sep 2026

Insomnia symptoms and stress exposure interact in relation to Alzheimer’s disease biomarkers

It is suggested that chronic stress and sleep disturbances exhibit an interactive relationship in their associations with AD pathology, and the need for further research into interactive effects of multiple modifiable risk factors in the development of AD is highlighted.

J. Holleman, I. Kåreholt, Manasa Shanta Näsholm et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.